{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T02:59:05Z","timestamp":1776308345154,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":448,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jtct.2021.12.006","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T03:06:16Z","timestamp":1639969576000},"page":"160.e1-160.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Incidence and Outcomes of Respiratory Failure after Nonmyeloablative Related Haploidentical Blood or Marrow Transplantation"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5472-7577","authenticated-orcid":false,"given":"R. Scott","family":"Stephens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8529-0585","authenticated-orcid":false,"given":"Kevin","family":"Psoter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian A.","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2021.12.006_bib0001","unstructured":"Phelan R, Arora M, Chen M. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides, 2020."},{"key":"10.1016\/j.jtct.2021.12.006_bib0002","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0003","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.12.006_bib0004","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.2016.70.7091","article-title":"Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes","volume":"35","author":"Scott","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2021.12.006_bib0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/bmt.2011.69","article-title":"Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS","volume":"47","author":"Luger","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0006","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/s41409-018-0181-x","article-title":"Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality","volume":"53","author":"Saillard","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0007","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/bmt.2008.203","article-title":"Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases","volume":"42","author":"Brodsky","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0008","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1200\/JCO.2014.60.4777","article-title":"Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults","volume":"33","author":"Kasamon","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2021.12.006_bib0009","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0010","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2012-07-438408","article-title":"HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease","volume":"120","author":"Bola\u00f1os-Meade","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.12.006_bib0011","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/bmt.2010.213","article-title":"Post-transplantation cyclophosphamide for GVHD prophylaxis in severe aplastic anemia","volume":"46","author":"Dezern","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0012","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.bbmt.2018.02.005","article-title":"Haploidentical bone marrow transplantation with post-transplant cyclophosphamide using non-first-degree related donors","volume":"24","author":"Elmariah","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0013","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/00003246-200005000-00011","article-title":"Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit","volume":"28","author":"Staudinger","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtct.2021.12.006_bib0014","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0308-2261(83)80007-1","article-title":"Application of bone marrow transplantation in leukaemia and aplastic anaemia","volume":"12","author":"Storb","year":"1983","journal-title":"Clin Haematol"},{"key":"10.1016\/j.jtct.2021.12.006_bib0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2141.1984.tb06056.x","article-title":"Bone marrow transplantation for acute lymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (EGBMT)","volume":"58","author":"Zwaan","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2021.12.006_bib0016","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-125-8-199610150-00001","article-title":"Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines","volume":"125","author":"Rubenfeld","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtct.2021.12.006_bib0017","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/bbmt.2001.v7.pm11349809","article-title":"Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation","volume":"7","author":"Ho","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0018","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.bmt.1705222","article-title":"Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter?","volume":"37","author":"Naeem","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0019","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1200\/JCO.2005.03.9073","article-title":"Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports","volume":"24","author":"P\u00e8ne","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2021.12.006_bib0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/cc8198","article-title":"Acute respiratory distress syndrome during neutropenia recovery","volume":"14","author":"Azoulay","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.jtct.2021.12.006_bib0021","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/bmt.2014.130","article-title":"Outcomes of stem cell transplant patients with acute respiratory failure requiring mechanical ventilation in the United States","volume":"49","author":"Allareddy","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0022","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bbmt.2012.09.010","article-title":"Use of mechanical ventilation and renal replacement therapy in critically ill hematopoietic stem cell transplant recipients","volume":"19","author":"Gilbert","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0023","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/CCM.0000000000001617","article-title":"Epidemiology of acute respiratory distress syndrome following hematopoietic stem cell transplantation","volume":"44","author":"Yadav","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtct.2021.12.006_bib0024","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00134-014-3354-0","article-title":"Acute respiratory distress syndrome in patients with malignancies","volume":"40","author":"Azoulay","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtct.2021.12.006_bib0025","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00134-018-5347-x","article-title":"Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients","volume":"44","author":"Lueck","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtct.2021.12.006_bib0026","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1513\/AnnalsATS.202004-336OC","article-title":"Pretransplant risk factors can predict development of acute respiratory distress syndrome after hematopoietic stem cell transplantation","volume":"18","author":"Herasevich","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jtct.2021.12.006_bib0027","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bbmt.2019.09.034","article-title":"Incidence, risk factors, and outcomes of idiopathic pneumonia syndrome after allogeneic hematopoietic cell transplantation","volume":"26","author":"Wenger","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0028","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2021.12.006_bib0029","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02617-2017","article-title":"Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation","volume":"51","author":"Bergeron","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtct.2021.12.006_bib0030","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bbmt.2014.02.011","article-title":"Screening with spirometry is a useful predictor of later development of noninfectious pulmonary syndromes in patients undergoing allogeneic stem cell transplantation","volume":"20","author":"Thompson","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0031","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure","volume":"372","author":"Frat","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.12.006_bib0032","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin Definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2021.12.006_bib0033","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1182\/blood-2004-03-0804","article-title":"Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors","volume":"104","author":"Diaconescu","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.12.006_bib0034","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1182\/blood-2004-02-0545","article-title":"Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities","volume":"104","author":"Sorror","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.12.006_bib0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbmt.2016.09.023","article-title":"The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease","volume":"23","author":"Cooke","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0036","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbmt.2016.11.016","article-title":"Nonmyeloablative haploidentical bone marrow transplantation with post-transplantation cyclophosphamide for pediatric and young adult patients with high-risk hematologic malignancies","volume":"23","author":"Klein","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0037","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bbmt.2006.05.012","article-title":"Diffuse alveolar hemorrhage: retrospective review of clinical outcome in allogeneic transplant recipients treated with aminocaproic acid","volume":"12","author":"Wanko","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0038","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/bmt.2014.287","article-title":"Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage","volume":"50","author":"Rathi","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0039","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2021004916","article-title":"Haploidentical vs. sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia [e-pub ahead of print]","author":"Wieduwilt","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2021.12.006_bib0040","doi-asserted-by":"crossref","DOI":"10.4161\/2162402X.2014.974393","article-title":"Situational aldehyde dehydrogenase expression by regulatory T cells may explain the contextual duality of cyclophosphamide as both a pro-inflammatory and tolerogenic agent","volume":"4","author":"Kanakry","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jtct.2021.12.006_bib0041","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1165\/rcmb.2014-0327OC","article-title":"Regulatory T cell DNA methyltransferase inhibition accelerates resolution of lung inflammation","volume":"52","author":"Singer","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jtct.2021.12.006_bib0042","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa032193","article-title":"Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome","volume":"351","author":"Brower","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.12.006_bib0043","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-2600(18)30345-X","article-title":"Acute respiratory failure in immunocompromised adults","volume":"7","author":"Azoulay","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jtct.2021.12.006_bib0044","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/bmt.2013.141","article-title":"Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT","volume":"49","author":"Benz","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0045","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/tri.12779","article-title":"Lung function score including a parameter of small airway disease as a highly predictive indicator of survival after allogeneic hematopoietic cell transplantation","volume":"29","author":"Nakamae","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.jtct.2021.12.006_bib0046","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.bbmt.2008.12.509","article-title":"Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility?","volume":"15","author":"Chien","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0047","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1513\/AnnalsATS.201304-097OC","article-title":"Pneumonia during remission induction chemotherapy in patients with acute leukemia","volume":"10","author":"Garcia","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jtct.2021.12.006_bib0048","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.hoc.2019.10.002","article-title":"Genetic predisposition to myelodysplastic syndrome in clinical practice","volume":"34","author":"Schratz","year":"2020","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jtct.2021.12.006_bib0049","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.healun.2014.11.010","article-title":"Severe hematologic complications after lung transplantation in patients with telomerase complex mutations","volume":"34","author":"Borie","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jtct.2021.12.006_bib0050","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/bloodadvances.2020003922","article-title":"Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide","volume":"5","author":"DeZern","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2021.12.006_bib0051","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","article-title":"The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy","volume":"127","author":"Kollman","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.12.006_bib0052","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev-pathol-011110-130158","article-title":"The acute respiratory distress syndrome: pathogenesis and treatment","volume":"6","author":"Matthay","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jtct.2021.12.006_bib0053","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.bbmt.2020.06.029","article-title":"Optimal donor for African Americans with hematologic malignancy: HLA-haploidentical relative or umbilical cord blood transplant","volume":"26","author":"Solomon","year":"2020","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672101438X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672101438X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:01:54Z","timestamp":1763002914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672101438X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S266663672101438X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.12.006","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Outcomes of Respiratory Failure after Nonmyeloablative Related Haploidentical Blood or Marrow Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}